Risk Of Developing Liver Cancer After HCV Treatment

▼
Showing posts with label Investment News HCV Drugs. Show all posts
Showing posts with label Investment News HCV Drugs. Show all posts
Friday, September 30, 2011

T.G.I.F Hepatitis News Ticker; Hep C Drugs:Bristol-Myers, Merck and Vertex

›
New On The Blog AASLD- Abstracts To Be Presented At The Nov Meeting; AASLD-Vertex presentation of New Data; INCIVEK™and VX-222 AASLD-New Dat...
Tuesday, September 6, 2011

Dramatic Changes in Hepatitis C Treatment Expected to Continue

›
Dramatic Changes in Hepatitis C Treatment Expected to Continue From Anadys Pharmaceuticals President and CEO Steve Worland Steve Worland ...
Monday, May 2, 2011

Analyst; Telaprevir – the Mightiest in the Land

›
Off The Cuff Thought this might be interesting, below is a bit of info from the investment site  istockanalyst ........ Telaprevir – the ...
Thursday, February 3, 2011

Vertex reports a loss:Spent more money to develop its hepatitis C drug candidate telaprevir along with other drugs

›
Vertex books bigger 4Q loss on research costs Feb 3, 2011 6:13 PM ET By The Associated Press CAMBRIDGE, Mass. (AP) — Vertex Pharmaceuticals ...
Tuesday, January 18, 2011

Medical Technology: U.S. consumers “could eventually be last in line”

›
18 Jan 2011 09:00 Noted From The WSJ: The U.S. is losing ground to emerging-market countries such as China, India and Brazil as a center o...
Thursday, December 30, 2010

2011 Hepatitis C And Wall Street/ Part Two

›
. 2010 Archives Part One Hepatitis C Drugs and Wall Street . For Future Updates Please See ; HCV In The News . . Part Two : 2011 HCV and W...